Have the Allhat, Anbp2, and Ascotbpla trials improved our knowledge of antihypertensive treatment?

Authors

  • Isabel Santos Centro de Saúde de Oeiras Departamento de Clínica Geral- Faculdade de Ciências Médicas- UNL

DOI:

https://doi.org/10.32385/rpmgf.v22i4.10272

Downloads

Download data is not yet available.

Downloads

Published

2006-07-01

Issue

Vol. 22 No. 4 (2006): Revista Portuguesa de Clínica Geral

Section

Reading Club

License

The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.

The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.

 

How to Cite

Have the Allhat, Anbp2, and Ascotbpla trials improved our knowledge of antihypertensive treatment?. (2006). Portuguese Journal of Family Medicine and General Practice, 22(4), 537. https://doi.org/10.32385/rpmgf.v22i4.10272

Most read articles by the same author(s)

1 2 3 4 > >>